Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
79.6M
-
Number of holders
-
32
-
Total 13F shares, excl. options
-
8.32M
-
Shares change
-
+8.28M
-
Total reported value, excl. options
-
$89M
-
Value change
-
+$88.6M
-
Number of buys
-
30
-
Price
-
$10.70
Significant Holders of Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) as of Q1 2021
32 filings reported holding ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share as of Q1 2021.
Eledon Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (ELDN) has 32 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8.32M shares
of 79.6M outstanding shares and own 10.44% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LP (1.42M shares), FMR LLC (1.35M shares), EcoR1 Capital, LLC (1.12M shares), BVF INC/IL (1.11M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (893K shares), Woodline Partners LP (891K shares), Ikarian Capital, LLC (250K shares), VANGUARD GROUP INC (230K shares), Logos Global Management LP (224K shares), and JANUS HENDERSON GROUP PLC (214K shares).
This table shows the top 32 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.